Lombard Odier Asset Management Europe Ltd Makes New $8.31 Million Investment in Corteva, Inc. $CTVA

Lombard Odier Asset Management Europe Ltd acquired a new stake in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, HoldingsChannel reports. The firm acquired 98,165 shares of the company’s stock, valued at approximately $8,314,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CTVA. Kingsview Wealth Management LLC bought a new position in Corteva in the 2nd quarter worth approximately $1,093,000. Beacon Pointe Advisors LLC bought a new position in Corteva in the 2nd quarter worth about $3,317,000. Kimelman & Baird LLC bought a new position in shares of Corteva in the second quarter worth approximately $563,000. Pin Oak Investment Advisors Inc. purchased a new stake in shares of Corteva during the 2nd quarter valued at $48,000. Finally, Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Corteva during the second quarter valued at about $116,000. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of CTVA opened at $84.00 on Friday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The firm has a fifty day simple moving average of $82.69 and a two-hundred day simple moving average of $80.54. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The firm has a market cap of $56.04 billion, a PE ratio of 55.63, a P/E/G ratio of 2.53 and a beta of 0.57.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period last year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s payout ratio is 47.68%.

Wall Street Analysts Forecast Growth

Several research firms have commented on CTVA. BMO Capital Markets lifted their price target on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, August 3rd. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Royal Bank Of Canada reaffirmed an “overweight” rating on shares of Corteva in a research note on Friday. Mizuho upped their price target on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. Finally, Morgan Stanley upped their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.